Ryvu Therapeutics S.A. announced that it has received 22 million in a round of funding from new investor, European Fund for Strategic Investments, a fund managed by European Investment Bank, Investment Arm on August 17, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
54.6 PLN | -0.73% | +7.69% | -5.04% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.04% | 325M | |
+8.29% | 114B | |
+10.21% | 104B | |
-11.90% | 22.41B | |
+0.29% | 22.28B | |
-5.57% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- RVU Stock
- News Ryvu Therapeutics S.A.
- Ryvu Therapeutics S.A. announced that it has received €22 million in funding from European Investment Bank, Investment Arm